4.8 Review

The cytokine network in asthma and chronic obstructive pulmonary disease

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 118, Issue 11, Pages 3546-3556

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI36130

Keywords

-

Funding

  1. AstraZeneca
  2. Boehringer-Ingelheim
  3. Dainippon-Sumitoma Pharma
  4. Daiichi-Sankyo Co.
  5. GlaxoSmithKline
  6. Novarris

Ask authors/readers for more resources

Asthma and chronic obstructive pulmonary disease (COPD) are very common inflammatory diseases of the airways. They both cause airway narrowing and are increasing in incidence throughout the world, imposing enormous burdens on health care. Cytokines play a key role in orchestrating the chronic inflammation and structural changes of the respiratory tract in both asthma and COPD and have become important targets for the development of new therapeutic strategies in these diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available